0001225208-18-008853.txt : 20180507 0001225208-18-008853.hdr.sgml : 20180507 20180507213559 ACCESSION NUMBER: 0001225208-18-008853 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180507 FILED AS OF DATE: 20180507 DATE AS OF CHANGE: 20180507 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MUSSALLEM MICHAEL A CENTRAL INDEX KEY: 0001204551 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15525 FILM NUMBER: 18812782 MAIL ADDRESS: STREET 1: C/O EDWARDS LIFESCIENCES CORP STREET 2: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Edwards Lifesciences Corp CENTRAL INDEX KEY: 0001099800 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 364316614 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 BUSINESS PHONE: 9492502500 MAIL ADDRESS: STREET 1: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 FORMER COMPANY: FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP. DATE OF NAME CHANGE: 20090225 FORMER COMPANY: FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP DATE OF NAME CHANGE: 20000203 FORMER COMPANY: FORMER CONFORMED NAME: CVG CONTROLLED INC DATE OF NAME CHANGE: 19991126 4 1 doc4.xml X0306 4 2018-05-07 0001099800 Edwards Lifesciences Corp EW 0001204551 MUSSALLEM MICHAEL A ONE EDWARDS WAY IRVINE CA 92614 1 1 Chairman & CEO Common Stock 2018-05-07 4 M 0 19800.0000 44.6150 A 61130.8200 D Common Stock 2018-05-07 4 M 0 13000.0000 42.7250 A 74130.8200 D Common Stock 2018-05-07 4 S 0 1871.0000 135.7918 D 72259.8200 D Common Stock 2018-05-07 4 S 0 30929.0000 136.4008 D 41330.8200 D Common Stock 123931.0030 I 401(k) Common Stock 698095.0000 I By Living Trust Employee Stock Option (Right to Acquire) 42.7250 2018-05-07 4 M 0 13000.0000 0.0000 D 2012-06-09 2019-05-08 Common Stock 13000.0000 319800.0000 D Employee Stock Option (Right to Acquire) 44.6150 2018-05-07 4 M 0 19800.0000 0.0000 D 2011-06-12 2018-05-11 Common Stock 19800.0000 0.0000 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2017. This transaction was executed in multiple trades at prices ranging from $135.06 to $136.0550. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $136.0750 to $137.1950. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Shares represented on the most recent statement of Issuer's 401(k) Plan Administrator where a unitized accounting procedure is utilized to convert the equity to share equivalents. This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. Linda J. Park, Attorney-in-Fact 2018-05-07